INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe

FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe

These are the Vaccines by another name FFS!

Hedley Rees's avatar
Hedley Rees
Jan 30, 2024
∙ Paid
15

Share this post

INSIDE PHARMA
INSIDE PHARMA
FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe
6
1
Share

This is an incredibly positive development

We should take heart from this important step from FDA

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share